Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vor Biopharma Inc.

0.6864
+0.03645.60%
Volume:205.36K
Turnover:140.59K
Market Cap:85.70M
PE:-0.40
High:0.7064
Open:0.7000
Low:0.6613
Close:0.6500
Loading ...

We're A Little Worried About Vor Biopharma's (NASDAQ:VOR) Cash Burn Rate

Simply Wall St.
·
09 Apr

Here's Why Vor Biopharma (NASDAQ:VOR) Must Use Its Cash Wisely

Simply Wall St.
·
31 Mar

Optimistic Buy Rating for Vor Biopharma Amidst Economic Challenges and Promising Clinical Potential

TIPRANKS
·
29 Mar

Vor Biopharma Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
21 Mar

Vor Biopharma Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
21 Mar

BRIEF-Vor Biopharma Inc Files For Mixed Shelf Offering Of Up To $350 Million

Reuters
·
21 Mar

Vor Bio files $350M mixed securities shelf

TIPRANKS
·
21 Mar

Vor Biopharma Inc: Files for Mixed Shelf Offering of up to $350 Mln - SEC Filing

THOMSON REUTERS
·
21 Mar

Vor Biopharma FY 2024 GAAP EPS $(1.70) Misses $(1.40) Estimate

Benzinga
·
21 Mar

Vor Biopharma: Projected to Fund Operations Into the First Quarter of 2026

THOMSON REUTERS
·
21 Mar

Vor Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Company Update

THOMSON REUTERS
·
21 Mar

Press Release: Vor Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Company Update

Dow Jones
·
21 Mar

Vor Biopharma Inc expected to post a loss of 29 cents a share - Earnings Preview

Reuters
·
14 Mar

Vor Bio Presents Novel Research Highlighting Opportunities and Challenges Facing Institutions Enrolling Patients in Cell and Gene Therapy Trials

THOMSON REUTERS
·
13 Feb

Vor Bio Presents Novel Research Highlighting Opportunities and Challenges Facing Institutions Enrolling Patients in Cell and Gene Therapy Trials

GlobeNewswire
·
13 Feb

Vor Biopharma Approves Stock Option Repricing Strategy

TIPRANKS
·
07 Feb

Vor Bio to Participate in the Oppenheimer's 35th Annual Healthcare Life Sciences Conference

GlobeNewswire
·
03 Feb

Vor Biopharma Inc. (VOR)'s Technical Outlook is Bright After Key Golden Cross

Zacks
·
27 Jan

Vor Biopharma Files Secondary Common Stock Shelf

MT Newswires Live
·
22 Jan

BRIEF-Vor Bio Appoints Erez Kalir To Its Board Of Directors

Reuters
·
08 Jan